Re: A message from the “infamous Cookiemonster”
in response to
by
Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications
Message: Re: A message from the “infamous Cookiemonster”
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Welcome to the forum Tony. I don’t know who you are but you appear to not have a complete picture or a lack of understanding. Maybe it is because you are very young and think you know everything like most of us are when we are new to the game.
Anyway I don’t think you have really been following the forum very closely because there is a really good example for you to do comparisons with.
I am going to be talking from memory which is not always the best but here we go.
A pretty good example of extreme success in terms of the benefits and that exposure associated with a NASDAQ listing is LWLG. They were originally more of a material science company working with Electro-Optic Polymer. I spent some time looking into the history and developments and read a couple papers written by the principals of the company. Anyway I don’t want to discuss the merits of technology but they don’t have a product yet. They are still working on Process Development Kits.
So how can it be that LWLG with no product gets listed on the NASDAQ and goes up 2000%. It has come down and is only up by 1000% as we speak.
Insiders of LWLG definitely made some quick cash in December when the price peaked:
|
DATE |
NAME |
SHARES TRADED |
TRANSACTION |
VALUE |
SHARES HELD |
|
2021-12-27 |
Thomas E. Zelibor |
0 |
None |
$0.00 |
160,524 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $16.76 per share |
-$83,800.00 |
160,524 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $16.67 per share |
-$83,355.00 |
170,524 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $16.70 per share |
-$83,500.00 |
165,524 |
|
2021-12-27 |
Thomas E. Zelibor |
-3,060 |
Sell at $16.66 per share |
-$50,979.60 |
175,524 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $17.15 per share |
-$85,750.00 |
183,584 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $17.40 per share |
-$87,000.00 |
193,584 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $17.09 per share |
-$85,465.00 |
203,584 |
|
2021-12-27 |
Ronald A. Bucchi |
0 |
None |
$0.00 |
46,309 |
|
2021-12-27 |
Ronald A. Bucchi |
-39,203 |
Sell at $16.90 per share |
-$662,569.88 |
46,309 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $17.51 per share |
-$87,560.00 |
198,584 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $17.25 per share |
-$86,250.00 |
188,584 |
|
2021-12-27 |
Thomas E. Zelibor |
-5,000 |
Sell at $17.15 per share |
-$85,750.00 |
178,584 |
|
2021-12-23 |
Thomas E. Zelibor |
-29,611 |
Sell at $16.75 per share |
-$496,013.88 |
208,584 |
|
2021-12-23 |
Ronald A. Bucchi |
-27,988 |
Sell at $16.74 per share |
-$468,575.09 |
85,512 |
|
2021-12-22 |
Thomas E. Zelibor |
0 |
None |
$0.00 |
238,195 |
|
2021-12-22 |
Thomas E. Zelibor |
-22,329 |
Sell at $16.71 per share |
-$373,184.56 |
238,195 |
|
2021-12-22 |
Thomas E. Zelibor |
-36,203 |
Sell at $17.02 per share |
-$616,211.25 |
274,321 |
|
2021-12-22 |
Ronald A. Bucchi |
-10,500 |
Sell at $16.70 per share |
-$175,350.00 |
163,500 |
|
2021-12-22 |
Ronald A. Bucchi |
-30,086 |
Sell at $16.93 per share |
-$509,355.97 |
133,414 |
|
2021-12-22 |
Ronald A. Bucchi |
-19,914 |
Sell at $16.91 per share |
-$336,686.00 |
113,500 |
|
2021-12-22 |
Thomas E. Zelibor |
-13,797 |
Sell at $17.02 per share |
-$234,880.12 |
260,524 |
|
2021-11-20 |
Thomas E. Zelibor |
-14,475 |
Sell at $13.53 per share |
-$195,846.75 |
310,524 |
|
2021-11-20 |
Thomas E. Zelibor |
-101,373 |
Sell at $14.04 per share |
-$1,423,276.00 |
324,999 |
|
2021-11-19 |
Thomas E. Zelibor |
0 |
None |
$0.00 |
426,372 |
|
2021-11-19 |
Thomas E. Zelibor |
-49,106 |
Sell at $14.59 per share |
-$716,456.56 |
425,972 |
|
2021-11-19 |
Thomas E. Zelibor |
-75,046 |
Sell at $14.57 per share |
-$1,093,420.00 |
475,078 |
|
2021-11-19 |
Thomas E. Zelibor |
500,000 |
Option Excercise at $1.30 per share |
$650,000.00 |
550,124 |
|
2012-06-11 |
Ronald A. Bucchi |
0 |
None |
$0.00 |
160,600 |
|
2012-06-11 |
Ronald A. Bucchi |
0 |
None |
$0.00 |
107,600 |
|
2012-03-31 |
Thomas E. Zelibor |
0 |
None |
$0.00 |
43,424 |
|
2012-02-29 |
Thomas E. Zelibor |
1,406 |
Other at $1.40 per share |
$1,968.40 |
43,424 |
|
2011-12-31 |
Thomas E. Zelibor |
0 |
None |
$0.00 |
42,018 |
|
2011-10-31 |
Thomas E. Zelibor |
2,018 |
Other at $1.25 per share |
$2,522.50 |
42,018 |
|
-$7,466,744.76 |
A total of 500k options at a price of $1.30 were exercised so $650k went into the coffers.
Now consider what POETs situation is. And really it is a long list which makes this company prime to go on the NASDAQ.
It might be an idea for you Tony to make a list of the advantages that POET has in terms of production facilities and market readiness. Could be a good exercise to provide you with an understanding of just why POET wants to get on the NASDAQ ASAP.
32 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply